Imaging With [89Zr]Panitumumab-PET/MRI in Patients With Newly Diagnosed

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04186117` - Development of Clinical and Biological Database in Colorectal Cancer	N/A
Completed	`NCT05468892` - Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial	Phase 2
Recruiting	`NCT02291744` - A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients	Phase 2
Active, not recruiting	`NCT00986661` - A Study to Assess PV-10 Chemoablation of Cancer of the Liver	Phase 1
Completed	`NCT03176485` - Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors	N/A
Recruiting	`NCT05983367` - A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer	Phase 2
Recruiting	`NCT03730558` - ZETA : Prospective Observational Study
Recruiting	`NCT06180460` - CALM: Managing Distress in Malignant Brain Cancer	N/A
Active, not recruiting	`NCT03251378` - A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors, Colorectal, and Breast Cancer	Phase 1
Recruiting	`NCT04737213` - SGM-101 in Colorectal Lung Metastases	Phase 2
Recruiting	`NCT05714124` - Liver Embolization Approaches for Tumor Management
Recruiting	`NCT05396807` - REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients	N/A
Active, not recruiting	`NCT02724202` - Curcumin in Combination With 5FU for Colon Cancer	Early Phase 1
Recruiting	`NCT05848739` - A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors	Phase 1
Not yet recruiting	`NCT06202183` - Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial	N/A
Withdrawn	`NCT01936961` - Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors	N/A
Not yet recruiting	`NCT06358677` - Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Metastatic Colorectal Cancer	Phase 2
Completed	`NCT03415126` - A Study of ASN007 in Patients With Advanced Solid Tumors	Phase 1
Completed	`NCT02834052` - Pembrolizumab + Poly-ICLC in MRP Colon Cancer	Phase 1/Phase 2
Not yet recruiting	`NCT06446557` - De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer	Phase 3

NCT number	NCT03764137
Study type	Interventional
Source	University of Alabama at Birmingham
Contact
Status	Withdrawn
Phase	Phase 1/Phase 2
Start date	March 14, 2019
Completion date	January 2026

Imaging With [89Zr]Panitumumab-PET/MRI in Patients With Newly Diagnosed Colorectal Cancer — Panitumumab

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms